Form 4 for SANA Sana Biotechnology, Inc.
Accepted 2022-02-23 00:00:00 ET · period of report 2022-02-18 · accession 0001562180-22-001784 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-23 | 2021-11-15 | SANA | MacDonald James J. | EVP, GC | A - Grant | $18.23 | +1,000 | 429.8K | +0.2% | +$18.2K | |
| 2022-02-23 | 2022-02-18 | SANA | MacDonald James J. | EVP, GC | S - Sale | $6.28 | -333 | 429.4K | -0.1% | -$2,091 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-15 | A | A | 1,000 | $18.23 | 429,750 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on November 15, 2021. |
| 2 | Common | Common Stock | 2022-02-18 | S | D | 333 | $6.28 | 429,417 | D | — | — |